In this article
Dermatica describes its melasma service as a personalized prescription plan that can change with a patient’s progress. Its US pricing page currently advertises a two-month plan at $59.90, expressed as $29.95 per bottle, with free shipping. The treatment and pricing pages also describe deliveries approximately every 56 days, so the actual renewal date deserves confirmation.
The offer is broader than a single cream with one public ingredient list. A clinician chooses the formula after assessing the concern and relevant history. This review examines that service structure and the published options; it does not guarantee a hydroquinone prescription or treat every ingredient displayed on Dermatica’s website as part of every patient’s bottle.
The ingredient menu is not your prescription
Dermatica’s melasma page discusses ingredients including hydroquinone, azelaic acid, tretinoin, and fluocinolone acetonide. It shows concentrations or ranges for those possible ingredients. A reader should understand them as information about treatment options, not an instruction to combine all of them or request the highest number available.
The useful next document is the actual prescription, identifying the ingredients and strengths chosen for the assessed condition. Ask why each is included and what role it has in the plan. If a product contains a corticosteroid, for example, its presence needs an understood purpose and duration rather than being treated as a general moisturizing feature.
Why the diagnosis comes first
Melasma can produce areas of uneven pigmentation, but a person cannot reliably identify every brown patch or discrete spot from its color alone. The American Academy of Dermatology explains that an examination may be needed to distinguish conditions and choose treatment. A service’s online process should not be read as permission to bypass assessment of a concerning lesion.
If the concern is a new, changing, itching, or bleeding spot, seek a professional skin assessment before buying a fading treatment. Our comparison of melasma, sun spots, and post-acne marks explains why the starting question changes the treatment discussion. A prescription offer becomes meaningful only when it is connected to the right concern.
Read the two-month plan carefully
The current US pricing page states $29.95 per bottle and $59.90 every two months. It also describes formula delivery every 56 days. Those phrases are close in ordinary conversation but do not always produce the same calendar date. Check the account’s actual billing and delivery schedule rather than assuming renewals fall on the same date each month.
The page lists free shipping, dermatology check-ins, formula adaptations, and options to edit delivery dates or cancel. Verify the selected plan and any introductory terms during checkout. Our dark spot cream cost guide keeps recurring charges separate from trial promotions and from the advertised monthly equivalent.
Monitoring is part of the proposition
Dermatica says it monitors progress and can adjust treatment. That is a service feature worth understanding in detail. Ask how reviews are initiated, whether photographs are requested through a secure clinical process, and what happens if a reaction occurs between scheduled contacts. Also clarify whether all the follow-up you expect is included.
A change in formula is a new set of instructions to read. Do not continue the old directions automatically because the bottle or subscription still has the same brand name. Ask what has changed, why, and whether anything else in the routine should be reconsidered. Keeping earlier labels can help the clinician understand what was used.
Published ingredient evidence has boundaries
TRI-LUMA’s label covers a specific approved combination for short-term treatment of moderate-to-severe facial melasma alongside sun-avoidance measures. It is useful context when discussing similar ingredient names, but it is not approval of a different personalized compounded preparation. A matching ingredient does not make two finished medications equivalent.
FDA explains that compounded drugs are not FDA approved and do not undergo its premarket evaluation of the finished product. This review did not establish controlled evidence for every possible individualized Dermatica formula. We therefore do not convert the service’s marketing timeline into an expected outcome or rank it medically above the other providers.
Comfort and daily protection affect the plan
Dermatology guidance emphasizes sun protection and avoiding irritation when managing pigmentation. A product described as having a hydrating base can still be unsuitable or irritating for an individual. Tell the clinician about cleansers, acids, retinoids, peels, and other treatments already used, including occasional products that may not feel like part of the daily routine.
Ask for instructions about the treatment area, planned duration, and what to do if the skin becomes uncomfortable or changes unexpectedly. The hydroquinone guide explains why a defined review point matters. A subscription renewal should not silently become a decision to continue a medication indefinitely.
Comparing this service with the featured partner
CoreAge Rx Spot On publicly names hydroquinone, kojic acid, and niacinamide and advertises a starting monthly price. Dermatica describes a clinician-selected treatment plan and a two-month billing arrangement. Those differences are useful purchasing information; they do not establish which prescription would be appropriate for the same person.
Use the expandable comparison records to keep the public details visible, then replace unanswered fields with confirmed consultation information. CoreAge’s first position is commercial. Dermatica’s personalization language is a provider description. Neither can substitute for identifying the treatment and understanding its instructions.
Before enrolling
Request the exact formula, quantity, dispensing details, storage information, and any beyond-use date that applies. Clarify medical support access, the renewal date, and the process for changing future supply. Discuss relevant health history, other medications, and pregnancy or breastfeeding considerations before a prescription decision.
Dermatica is a service to investigate when someone wants a monitored online assessment for an appropriate concern. Its usefulness depends on the actual plan and communication, not simply on the length of its ingredient menu. The clearest decision is one in which the patient understands both the clinical review point and the next financial commitment.
THE SOURCE MATERIAL
Read the originals.
Public information checked September 24, 2026. A commercial page supports offer details; it does not independently validate the treatment claims.
- Dermatica — Melasma treatment ↗
Provider description of personalized formulas and possible active ingredients. The listed ingredients are not a guaranteed prescription.
- Dermatica — US pricing ↗
Advertises $29.95 per bottle and $59.90 every two months, with free shipping. Delivery is also described as every 56 days; confirm the actual billing date.
- American Academy of Dermatology — Melasma diagnosis and treatment ↗
Medical guidance on diagnosis, treatment options, and sun protection. It does not endorse the commercial order used here.
- FDA — Understanding the risks of compounded drugs ↗
Compounded preparations are not FDA approved and do not receive the finished-product premarket review used for approved drugs.
- DailyMed — TRI-LUMA prescribing information ↗
Product-specific label for short-term treatment of moderate-to-severe facial melasma with sun-avoidance measures. Not evidence for every hydroquinone mixture.